Search - tctmd.com

Displaying 441 - 460 of 461

Sort: Relevancy | Date

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

June 09, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

News Industry News

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

March 08, 2011

News Daily News

Platelet Assay May Help Predict Major Bleeding after PCI

L.A. McKeown

February 03, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Caitlin E. Cox

January 25, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

L.A. McKeown

January 03, 2011

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

CME

Aspirin for the Interventionalist: More Than Meets the Eye

CME

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Partner Content

CME Landing Page

November 22, 2016

Advertisement

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Ticagrelor Gains FDA Approval for Use in ACS

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

Platelet Assay May Help Predict Major Bleeding after PCI

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Aspirin for the Interventionalist: More Than Meets the Eye

Everyday Antiplatelet Decisions: Making the Right Choices

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME Landing Page

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content